國立虎尾科技大學 |

In vivo reprogramming in regenerative medicine

Record Type:	Language materials, printed : Monograph/item
Title/Author:	In vivo reprogramming in regenerative medicine/ edited by Acelya Yilmazer.
other author:	Yilmazer, Acelya.
Published:	Cham :Springer International Publishing : : 2017.,
Description:	xvii, 103 p. :ill., digital ; : 24 cm.;
Contained By:	Springer eBooks
Subject:	Regenerative medicine. -
Online resource:	http://dx.doi.org/10.1007/978-3-319-65720-2
ISBN:	9783319657202

In vivo reprogramming in regenerative medicine
In vivo reprogramming in regenerative medicine[electronic resource] /edited by Acelya Yilmazer. - Cham :Springer International Publishing :2017. - xvii, 103 p. :ill., digital ;24 cm. - Stem cell biology and regenerative medicine,2196-8985. - Stem cell biology and regenerative medicine..

Chapter 1. Introduction to in vivo cell Reprogramming Technology -- Chapter 2. In vivo Reprogramming for Regenerating Insulin-Secreting Cells -- Chapter 3. Direct Reprogramming to Beta Cells -- Chapter 4. In vivo Lineage Reprogramming of Fibroblasts to Cardiomyocytes for Heart Regeneration -- Chapter 5: In vivo cell Reprogramming for Long-term Pluripotency -- Chapter 6: In vivo Transient Reprogramming Towards Pluripotency for Tissue Repair and Regeneration -- Chapter 7. Challenges and Future Perspectives for in vivo Reprogramming Technology.

There have been significant improvements in the development of cell based therapies; however, current treatment strategies still suffer from some problems: the need for long in vitro culture conditions, inefficient delivery of cells by scaffolds and low incorporation and grafting efficiencies. Therefore, in vivo reprogramming has emerged as a novel treatment technology. In the process of in vivo reprogramming, cells switch to another cell type within the living organism. Leaders in the field discuss how in vivo reprogramming can be used for tissue repair and regeneration in different organs, including pancreas, liver and heart. Furthermore, recent studies on in vivo cell reprogramming towards pluripotency are also reviewed. Current challenges of these preclinical studies are discussed and hypothesis and suggestions are given in order to improve the current strategies to achieve translation into clinic.

ISBN: 9783319657202

Standard No.: 10.1007/978-3-319-65720-2doiSubjects--Topical Terms:

782729
Regenerative medicine.

LC Class. No.: R856

Dewey Class. No.: 610.28

In vivo reprogramming in regenerative medicine
LDR:02465nam a2200325 a 4500 001 921814
003 DE-He213
005 20180511134159.0
006 m d
007 cr nn 008maaau
008 190624s2017 gw s 0 eng d
020 $a 9783319657202 $q (electronic bk.)
020 $a 9783319657196 $q (paper)
024 7 $a 10.1007/978-3-319-65720-2 $2 doi
035 $a 978-3-319-65720-2
040 $a GP $c GP
041 0 $a eng
050 4 $a R856
072 7 $a PSF $2 bicssc
072 7 $a SCI049000 $2 bisacsh
082 0 4 $a 610.28 $2 23
090 $a R856 $b .I35 2017
245 0 0 $a In vivo reprogramming in regenerative medicine $h [electronic resource] / $c edited by Acelya Yilmazer.
260 $a Cham : $c 2017. $b Springer International Publishing : $b Imprint: Humana Press,
300 $a xvii, 103 p. : $b ill., digital ; $c 24 cm.
490 1 $a Stem cell biology and regenerative medicine, $x 2196-8985
505 0 $a Chapter 1. Introduction to in vivo cell Reprogramming Technology -- Chapter 2. In vivo Reprogramming for Regenerating Insulin-Secreting Cells -- Chapter 3. Direct Reprogramming to Beta Cells -- Chapter 4. In vivo Lineage Reprogramming of Fibroblasts to Cardiomyocytes for Heart Regeneration -- Chapter 5: In vivo cell Reprogramming for Long-term Pluripotency -- Chapter 6: In vivo Transient Reprogramming Towards Pluripotency for Tissue Repair and Regeneration -- Chapter 7. Challenges and Future Perspectives for in vivo Reprogramming Technology.
520 $a There have been significant improvements in the development of cell based therapies; however, current treatment strategies still suffer from some problems: the need for long in vitro culture conditions, inefficient delivery of cells by scaffolds and low incorporation and grafting efficiencies. Therefore, in vivo reprogramming has emerged as a novel treatment technology. In the process of in vivo reprogramming, cells switch to another cell type within the living organism. Leaders in the field discuss how in vivo reprogramming can be used for tissue repair and regeneration in different organs, including pancreas, liver and heart. Furthermore, recent studies on in vivo cell reprogramming towards pluripotency are also reviewed. Current challenges of these preclinical studies are discussed and hypothesis and suggestions are given in order to improve the current strategies to achieve translation into clinic.
650 0 $a Regenerative medicine. $3 782729
650 1 4 $a Life Sciences. $3 593888
650 2 4 $a Regenerative Medicine/Tissue Engineering. $3 1020916
650 2 4 $a Stem Cells. $3 782732
650 2 4 $a Cell Culture. $3 783886
650 2 4 $a Transplant Surgery. $3 674230
700 1 $a Yilmazer, Acelya. $3 1196987
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
830 0 $a Stem cell biology and regenerative medicine. $3 885215
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-65720-2
950 $a Biomedical and Life Sciences (Springer-11642)